| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;93:720-729.)
© 1996 American Heart Association, Inc.
Articles |
Induction of Nitric Oxide Synthase in the Human Cardiac Allograft Is Associated With Contractile Dysfunction of the Left Ventricle
Presented in part at the 67th Scientific Sessions of the American Heart Association, Dallas, Tex, November 14-17, 1994.
From the Divisions of Cardiovascular Medicine (N.P.L., P.S.T., P.R.R., G.A.H., H.v.d.L., P.T.T., J.P.C., S.A.H., H.A.V., M.B.F.) and Pathology (M.E.B.), Stanford (Calif) University School of Medicine; and Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville (C.X., R.A.J.).
Correspondence to Dr Neil P. Lewis, Division of Cardiovascular Medicine, Cardiopulmonary Transplant Center, Box 191, University of Virginia Health Sciences Center, Charlottesville, VA 22908. E-mail nlewis@virginia.edu.
Background The mechanisms underlying cardiac contractile dysfunction after transplantation remain poorly defined. Previous work has revealed that inducible nitric oxide synthase (iNOS) is expressed in the rat heterotopic cardiac allograft during rejection; resultant overproduction of nitric oxide (NO) might cause cardiac contractile dysfunction via the negative inotropic and cytotoxic actions of NO. In this investigation, we tested the hypothesis that induction of iNOS may occur and be associated with cardiac allograft contractile dysfunction in humans.
Methods and Results We prospectively studied 16 patients in the first year after cardiac transplantation at the time of serial surveillance endomyocardial biopsy. Clinical data, the results of biopsy histology, and echocardiographic and Doppler evaluation of left ventricular systolic and diastolic function were recorded. Total RNA was extracted from biopsy specimens, and mRNA for ß-actin, detected by reverse transcription–polymerase chain reaction (RT-PCR) using human specific primers, was used as a constitutive gene control; iNOS mRNA was similarly detected by RT-PCR using human specific primers. iNOS protein was detected in biopsy frozen sections by immunofluorescence. Myocardial cGMP was measured by radioimmunoassay, and serum nitrogen oxide levels (NOx=NO2+NO3) were measured by chemiluminescence. iNOS mRNA was detected in allograft myocardium at some point in each patient and in 59 of 123 biopsies (48%) overall. In individual patients, iNOS mRNA expression was episodic and time dependent; the frequency of expression was highest during the first 180 days after transplant (P=.0006). iNOS protein associated with iNOS mRNA was detected by immunofluorescence in cardiac myocytes. iNOS mRNA expression was not related to the ISHLT histological grade of rejection or to serum levels of NOx but was associated with increased levels of myocardial cGMP (P=.01) and with both systolic (P=.024) and diastolic (P=.006) left ventricular contractile dysfunction measured by echocardiography and Doppler.
Conclusions These data support a relation between iNOS mRNA expression and contractile dysfunction in the human cardiac allograft.
Key Words: transplantation • rejection • nitric oxide • heart failure
This article has been cited by other articles:
 |
|
 |
|
  N. Goren, J. Cuenca, P. Martin-Sanz, and L. Bosca Attenuation of NF-{kappa}B signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes Cardiovasc Res, November 1, 2004; 64(2): 289 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. FOGLI, P. NIERI, and M. C. BRESCHI The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage FASEB J, April 1, 2004; 18(6): 664 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Pieper, V. Nilakantan, G. Hilton, X. Zhou, A. K. Khanna, N. L. N. Halligan, C. C. Felix, B. Kampalath, O. W. Griffith, M. A. Hayward, et al. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H525 - H534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Stoica, D. K. Satchithananda, C. Atkinson, S. Charman, M. Goddard, and S. R. Large Heat shock protein, inducible nitric oxide synthase and apoptotic markers in the acute phase of human cardiac transplantation Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 932 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Pieper, V. Nilakantan, G. Hilton, N. L. N. Halligan, C. C. Felix, B. Kampalath, A. K. Khanna, A. M. Roza, C. P. Johnson, and M. B. Adams Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1542 - H1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Cohen, D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts Am J Physiol Cell Physiol, February 1, 2003; 284(2): C457 - C474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Szabolcs, J. Sun, N. Ma, A. Albala, R. R. Sciacca, G. B. Philips, J. Parkinson, N. Edwards, and P. J. Cannon Effects of Selective Inhibitors of Nitric Oxide Synthase-2 Dimerization on Acute Cardiac Allograft Rejection Circulation, October 29, 2002; 106(18): 2392 - 2396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Flanagan, C. D. Jennings, S. W. Goes, B. E. Caywood, R. Gross, A. M. Kaplan, and J. S. Bryson Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease J. Leukoc. Biol., October 1, 2002; 72(4): 762 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Linke, W. Li, H. Huang, Z. Wang, and T. H. Hintze Role of cardiac eNOS expression during pregnancy in the coupling of myocardial oxygen consumption to cardiac work Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1208 - H1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G.F Bronzwaer, C. Zeitz, C. A Visser, and W. J Paulus Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heart Cardiovasc Res, August 1, 2002; 55(2): 270 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qian, R. Gelzer-Bell, S.-x. Yang, W. Cao, T. Ohnishi, B. A. Wasowska, R. H. Hruban, E. R. Rodriguez, W. M. Baldwin III, and C. J. Lowenstein Inducible Nitric Oxide Synthase Inhibition of Weibel-Palade Body Release in Cardiac Transplant Rejection Circulation, November 6, 2001; 104(19): 2369 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sarkar, P. Vallance, and S. E. Harding Nitric oxide: not just a negative inotrope Eur J Heart Fail, October 1, 2001; 3(5): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hayashi, Y. Sawa, N. Fukuyama, H. Nakazawa, and H. Matsuda Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response Ann. Thorac. Surg., July 1, 2001; 72(1): 149 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aziz, R. A. Saad, M. Burgess, N. Yonan, P. Hasleton, and I. V. Hutchinson Transforming growth factor beta and myocardial dysfunction following heart transplantation Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 177 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Szabolcs, N. Ma, E. Athan, J. Zhong, M. Ming, R. R. Sciacca, J. Husemann, A. Albala, and P. J. Cannon Acute Cardiac Allograft Rejection in Nitric Oxide Synthase-2-/- and Nitric Oxide Synthase-2+/+ Mice : Effects of Cellular Chimeras on Myocardial Inflammation and Cardiomyocyte Damage and Apoptosis Circulation, May 22, 2001; 103(20): 2514 - 2520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Geller, S. H. Chia, Y. Takahashi, G. P. Yagnik, G. Tsoulfas, and N. Murase Protective Role of the L-Arginine-Nitric Oxide Synthase Pathway on Preservation Injury after Rat Liver Transplantation JPEN J Parenter Enteral Nutr, May 1, 2001; 25(3): 142 - 147. [Abstract] [PDF]
|
|
|
|
|
|
H. Itano, W. Zhang, J. H. Ritter, T. J. McCarthy, N. S. Yew, T. Mohanakumar, and G. A. Patterson Endobronchial transfection of naked viral interleukin-10 gene in rat lung allotransplantation Ann. Thorac. Surg., April 1, 2001; 71(4): 1126 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Wort, J. A. Mitchell, and T. W. Evans Inducible nitric oxide synthase: a tissue-specific affair? Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L387 - L389. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Andreka, J. Zang, C. Dougherty, T. I. Slepak, K. A. Webster, and N. H. Bishopric Cytoprotection by Jun Kinase During Nitric Oxide-Induced Cardiac Myocyte Apoptosis Circ. Res., February 16, 2001; 88(3): 305 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sarkar, P. Vallance, C. Amirmansour, and S. E. Harding Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides Cardiovasc Res, December 1, 2000; 48(3): 430 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Soto, C.-X. Jia, D. G. Rabkin, J. P. Hart, Y. M. Carter, M. J. Sardo, D. T. Hsu, P. E. Fisher, D. J. Pinsky, and H. M. Spotnitz Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 39 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Skarsgard, X. Wang, P. McDonald, A. H. Lui, E. K. Lam, B. M. McManus, C. van Breemen, and I. Laher Profound Inhibition of Myogenic Tone in Rat Cardiac Allografts Is Due to eNOS- and iNOS-Based Nitric Oxide and an Intrinsic Defect in Vascular Smooth Muscle Contraction Circulation, March 21, 2000; 101(11): 1303 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, N. Ma, M. J. Szabolcs, J. Zhong, E. Athan, R. R. Sciacca, R. E. Michler, G. D. Anderson, J. F. Wiese, K. M. Leahy, et al. Upregulation of COX-2 During Cardiac Allograft Rejection Circulation, February 1, 2000; 101(4): 430 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Shah Inducible nitric oxide synthase and cardiovascular disease Cardiovasc Res, January 1, 2000; 45(1): 148 - 155. [Full Text] [PDF]
|
|
|
|
 |
|
 R R Chaturvedi, V E Hjortdal, E V Stenbog, H B Ravn, P White, T D Christensen, A B Thomsen, J Pedersen, K E Sorensen, and A N Redington Inhibition of nitric oxide synthesis improves left ventricular contractility in neonatal pigs late after cardiopulmonary bypass Heart, December 1, 1999; 82(6): 740 - 744. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Arstall, D. B. Sawyer, R. Fukazawa, and R. A. Kelly Cytokine-Mediated Apoptosis in Cardiac Myocytes : The Role of Inducible Nitric Oxide Synthase Induction and Peroxynitrite Generation Circ. Res., October 29, 1999; 85(9): 829 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. de Frutos, L. S. de Miguel, M. Garcia-Duran, F. Gonzalez-Fernandez, J. A. Rodriguez-Feo, M. Monton, J. Guerra, J. Farre, S. Casado, and A. Lopez-Farre NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-alpha Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1317 - H1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Pinsky, W. Aji, M. Szabolcs, E. S. Athan, Y. Liu, Y. M. Yang, R. P. Kline, K. E. Olson, and P. J. Cannon Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1189 - H1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J Paulus and A. M Shah NO and cardiac diastolic function Cardiovasc Res, August 15, 1999; 43(3): 595 - 606. [Full Text] [PDF]
|
|
|
|
|
|
C. Heymes, M. Vanderheyden, J. G. F. Bronzwaer, A. M. Shah, and W. J. Paulus Endomyocardial Nitric Oxide Synthase and Left Ventricular Preload Reserve in Dilated Cardiomyopathy Circulation, June 15, 1999; 99(23): 3009 - 3016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Flesch, H. Kilter, B. Cremers, U. Laufs, M. Sudkamp, M. Ortmann, F. U. Muller, and M. Bohm Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1062 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Worrall, T. P. Misko, M. D. Botney, P. M. Sullivan, J.-J Hui, G. M. Suau, P. T. Manning, and T. B. Ferguson Jr Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection Ann. Thorac. Surg., March 1, 1999; 67(3): 716 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ravalli, A. Albala, M. Ming, M. Szabolcs, A. Barbone, R. E. Michler, and P. J. Cannon Inducible Nitric Oxide Synthase Expression in Smooth Muscle Cells and Macrophages of Human Transplant Coronary Artery Disease Circulation, June 16, 1998; 97(23): 2338 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimizu, K.-i. Kinugawa, Y. Sugishita, K. Sugishita, K. Harada, H. Matsui, O. Kohmoto, T. Serizawa, and T. Takahashi Molecular cloning and expression of inducible nitric oxide synthase in chick embryonic ventricular myocytes Cardiovasc Res, May 1, 1998; 38(2): 405 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Cannon, X. Yang, M. J. Szabolcs, S. Ravalli, R. R. Sciacca, and R. E. Michler The role of inducible nitric oxide synthase in cardiac allograft rejection Cardiovasc Res, April 1, 1998; 38(1): 6 - 15. [Full Text] [PDF]
|
|
|
|
|
|
J. Igarashi, M. Nishida, S. Hoshida, N. Yamashita, H. Kosaka, M. Hori, T. Kuzuya, and M. Tada Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes Am J Physiol Cell Physiol, January 1, 1998; 274(1): C245 - C252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Kinugawa, T. Shimizu, A. Yao, O. Kohmoto, T. Serizawa, and T. Takahashi Transcriptional Regulation of Inducible Nitric Oxide Synthase in Cultured Neonatal Rat Cardiac Myocytes Circ. Res., December 19, 1997; 81(6): 911 - 921. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft Circulation, November 18, 1997; 96(10): 3436 - 3442. [Abstract] [Full Text]
|
|
|
|
|
|
K. Graf, Y. S. Do, N. Ashizawa, W. P. Meehan, C. M. Giachelli, C. C. Marboe, E. Fleck, and W. A. Hsueh Myocardial Osteopontin Expression Is Associated With Left Ventricular Hypertrophy Circulation, November 4, 1997; 96(9): 3063 - 3071. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-L. Balligand and P. J. Cannon Nitric Oxide Synthases and Cardiac Muscle : Autocrine and Paracrine Influences Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1846 - 1858. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Flesch, H. Kilter, B. Cremers, O. Lenz, M. Südkamp, F. Kuhn-Regnier, and M. Böhm J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1340 - 1349. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. W. Simmons, D. Ungureanu-Longrois, G. K. Smith, T. W. Smith, and R. A. Kelly Glucocorticoids Regulate Inducible Nitric Oxide Synthase by Inhibiting Tetrahydrobiopterin Synthesis and L-Arginine Transport J. Biol. Chem., September 27, 1996; 271(39): 23928 - 23937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kelly, J.-L. Balligand, and T. W. Smith Nitric Oxide and Cardiac Function Circ. Res., September 1, 1996; 79(3): 363 - 380. [Full Text]
|
|
|
|
|
|
N. K. Worrall, T. P. Misko, P. M. Sullivan, J.-J. Hui, and T. B. Ferguson Jr Inhibition of Inducible Nitric Oxide Synthase Attenuates Established Acute Cardiac Allograft Rejection Ann. Thorac. Surg., August 1, 1996; 62(2): 378 - 385. [Abstract] [Full Text]
|
|
|
|
|
|
J. Heger, A. Godecke, U. Flogel, M. W. Merx, A. Molojavyi, W. N. Kuhn-Velten, and J. Schrader Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Does Not Result in Severe Cardiac Dysfunction Circ. Res., January 11, 2002; 90(1): 93 - 99. [Abstract] [Full Text] [PDF]
|
|